Cargando…
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial
INTRODUCTION: Diabetes mellitus and diabetic nephropathy (DN) are prevalent and costly to manage. DN is the leading cause of end-stage kidney disease. Conventional therapy blocking the renin–angiotensin system has only achieved limited effect in preserving renal function. Recent observational data s...
Autores principales: | Chan, Kam Wa, Ip, Tai Pang, Kwong, Alfred Siu Kei, Lui, Sing Leung, Chan, Gary Chi Wang, Cowling, Benjamin John, Yiu, Wai Han, Wong, Dickson Wai Leong, Liu, Yang, Feng, Yibin, Tan, Kathryn Choon Beng, Chan, Loretta Yuk Yee, Leung, Joseph Chi Kam, Lai, Kar Neng, Tang, Sydney Chi Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986085/ https://www.ncbi.nlm.nih.gov/pubmed/27496229 http://dx.doi.org/10.1136/bmjopen-2015-010741 |
Ejemplares similares
-
Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial
por: Chan, Kam Wa, et al.
Publicado: (2021) -
Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study
por: Chan, Kam Wa, et al.
Publicado: (2020) -
Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021) -
Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes
por: Chan, Kam Wa, et al.
Publicado: (2021) -
PRAgmatic Clinical Trial Design of Integrative MediCinE (PRACTICE): A Focus Group Series and Systematic Review on Trials of Diabetes and Kidney Disease
por: Chan, Kam Wa, et al.
Publicado: (2021)